59 Lipid lowering effects of rosuvastatin in HIV-infected patients on Highly Active Antiretroviral Therapy

Sunday, April 26, 2009
Humberto R. Jimenez, Pharm.D., BCPS , Saint Michael's Medical Center, Newark, NJ
Stephen Esker, Pharm.D. , Bristol-Myers Squibb Company, Plainsboro, NJ
Alexander Ganetsky, Pharm.D. , Bristol-Myers Squibb Company, Plainsboro, NJ
Jihad Slim, M.D. , Saint Michael's Medical Center, Newark, NJ